In addition, SUMOylated nuclear IL-33 can promote the production of interleukin 8 (IL-8), which stimulates the IL-8 signaling pathway in macrophages, thereby promoting the migration and polarization of macrophages to the tumor-permissible phenotype. Here, IL33 is linked to neoplasm.